Pharmabiz55m
Adcendo gets US FDA clearance to begin ADCElerate-01 phase I/II trial of ADCE-D01 in patients with metastatic and/or unresectable STS
Adcendo gets US FDA clearance to begin ADCElerate-01 phase I/II trial of ADCE-D01 in patients with metastatic and/or unresectable STS: Copenhagen, Denmark Wednesday, October 9, 20 ...
Pharmabiz1h
NIHR and the Office for Life Sciences fund new projects to drive earlier diagnosis of cancer
The NIHR and the Office for Life Sciences (OLS) have funded six projects through NIHR's Invention for Innovation (i4i) and the OLS Cancer Programme. These six projects are receiving almost £11 million ...
Pharmabiz2h
Aurigene announces phase 1 study for India’s first trial for novel autologous CAR-T cell therapy for multiple myeloma
Aurigene announces phase 1 study for India’s first trial for novel autologous CAR-T cell therapy for multiple myeloma: Our Bureau, Bengaluru Wednesday, October 9, 2024, 16:45 Hr ...
Pharmabiz2h
Dozee Shravan, an AI-powered remote parent health monitoring service launched for NRIs
Dozee Shravan, an AI-powered remote parent health monitoring service launched for NRIs: Our Bureau, Bengaluru Wednesday, October 9, 2024, 16:15 Hrs [IST] Dozee, India’s health A ...
Pharmabiz3h
ModeX Therapeutics secures $35 mn BARDA supplement to develop Covid multispecific antibodies and $16 mn to initiate influenza programme
Weston, Massachusetts Wednesday, October 9, 2024, 15:00 Hrs [IST] ...
Pharmabiz4h
Philips and Siloam Hospitals sign AI capability MoU to support Indonesia’s healthcare transformation strategy
Philips and Siloam Hospitals sign AI capability MoU to support Indonesia’s healthcare transformation strategy: Jakarta, Indonesia Wednesday, October 9, 2024, 14:30 Hrs [IST] Roy ...
Pharmabiz4h
GSK presents positive data from AReSVi-006 phase III trial of respiratory syncytial virus vaccine, Arexvy at CHEST 2024 annual meeting
GSK presents positive data from AReSVi-006 phase III trial of respiratory syncytial virus vaccine, Arexvy at CHEST 2024 annual meeting: London, UK Wednesday, October 9, 2024, 14:0 ...
Pharmabiz5h
The Roquette Foundation for Health announces the winner of its 3rd Research Prize in the field of health prevention
The Roquette Foundation for Health has awarded its 3rd Research Prize to scientist Delphine Payros and her team, for their work on the toxicity of multiple dietary exposures involving mycotoxins in ...
Pharmabiz6h
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries: London, UK Wednesday, October 9, 2024, 12:00 Hrs [IST] GSK plc announced that ...
Pharmabiz7h
Merck’s phase 3 KEYNOTE-689 trial of anti-PD-1 therapy, Keytruda to treat LA-HNSCC meets its primary endpoint of event-free survival
Rahway, New Jersey Wednesday, October 9, 2024, 11:00 Hrs [IST] ...
Pharmabiz8h
US FDA grants marketing authorization to Healgen Rapid Check Covid-19/Flu A&B antigen test
US FDA grants marketing authorization to Healgen Rapid Check Covid-19/Flu A&B antigen test: Maryland Wednesday, October 9, 2024, 10:00 Hrs [IST] The US Food and Drug Administratio ...
Pharmabiz9h
Boehringer gets US FDA breakthrough therapy designation and initiates two phase III trials in MASH for survodutide
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health., announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for ...